Caplin Point Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
November 09, 2023 at 02:10 am EST
Share
Caplin Point Laboratories Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 4,100.6 million compared to INR 3,590.5 million a year ago. Revenue was INR 4,304.9 million compared to INR 3,755.3 million a year ago. Net income was INR 1,148.7 million compared to INR 916.7 million a year ago. Basic earnings per share from continuing operations was INR 15.13 compared to INR 12.09 a year ago. Diluted earnings per share from continuing operations was INR 15.06 compared to INR 11.99 a year ago.
For the six months, sales was INR 8,053.8 million compared to INR 7,053.8 million a year ago. Revenue was INR 8,378.5 million compared to INR 7,358 million a year ago. Net income was INR 2,183 million compared to INR 1,766.6 million a year ago. Basic earnings per share from continuing operations was INR 28.75 compared to INR 23.31 a year ago. Diluted earnings per share from continuing operations was INR 28.61 compared to INR 23.1 a year ago.
Caplin Point Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in producing, developing, and marketing a range of generic formulations and branded products and exporting to overseas markets. Its products include tablets, dry syrups (bottles), soft gels, capsules, suppositories, liquid syrups (bottles), liquid injectables in ampoules and vials, lyophilized vials, prefilled syringes (PFS), emulsion injection in ampoules and vials, ophthalmic droppers, pre-mix bags, topicals and sachets (liquids and powders). It also manufactures a range of ointments, creams, gels and lotions. Its principal research and development facilities are in Tamil Nadu, India. Its principal manufacturing facility is in Puducherry, India. It has presence in Latin America (LATAM), Southern Africa and Francophone Africa along with a presence in United States of America and European region. The Companyâs subsidiaries include Caplin Point Far East Limited and Caplin Steriles Limited.
CAPLIN POINT LABORATORIES LIMITED 
